Showing results (91-100 of 120) with videos related to
Sort By:
Pageof 12
Journal of the American Academy of Dermatology|November 21, 1997
Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgarisA W Lucky, T A Henderson, W H Olson, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|May 12, 2019
Use of dose-exposure-response relationships in Phase 2 and Phase 3 guselkumab studies to optimize dose selection in psoriasisM Lebwohl, R G Langley, Y Zhu, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|June 30, 2021
Three-year efficacy and safety of certolizumab pegol for the treatment of plaque psoriasis: results from the randomized phase 3 CIMPACT trialR B Warren, M Lebwohl, H Sofen, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|April 15, 2020
Safety in moderate-to-severe plaque psoriasis patients with latent tuberculosis treated with guselkumab and anti-tuberculosis treatments concomitantly: results from pooled phase 3 VOYAGE 1 & VOYAGE 2 trialsL Puig, T-F Tsai, T Bhutani, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|September 23, 2018
Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: pooled analysis of week 16 data from three randomized controlled trialsA Blauvelt, K Reich, M Lebwohl, et al.Pediatric Dermatology|March 18, 2000
Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotypeZ Urbán, S Peyrol, H Plauchu, et al.Antiviral Research|March 11, 1992
Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalisM Lebwohl, S Sacks, M Conant, et al.Journal of the European Academy of Dermatology and Venereology : JEADV|July 29, 2014
Physician perceptions and experience of current treatment in actinic keratosisE Stockfleth, K Peris, C Guillen, et al.The British Journal of Dermatology|February 22, 2011
Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studiesK Reich, R G Langley, M Lebwohl, et al.Journal of Psoriasis and Psoriatic Arthritis|September 19, 2024
The Disease Burden of Generalized Pustular Psoriasis: Real-World Evidence From CorEvitas' Psoriasis RegistryM Lebwohl, R A Medeiros, R H Mackey, et al.Pageof 12